Elite's Unique second generation IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone. Drug C in below table. The holy grail of IR ADFs trials resume in 2020 Making others obsolete.
Hammer locking the IR ADF market in 2021
Patent Pending
Quote Nasrat:
“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “